Sixty percent of pilocytic astrocytomas (WHO grade I) displayed focal GAL-immunoreactivity (<1–18% GAL-positive tumor cells; Figure 4A, Table 1, Supplementary Table 3). The gene discussed is GAL; the disease is neoplasm.